Sources | Names Used |
---|---|
CCLE, GDSC1000, GRAY, FIMM | Sorafenib |
CTRPv2 | sorafenib |
PharmacoGx | Sorafenib |
Database | Identifier |
---|---|
Smiles: | CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F |
Inchikey: | MLDQJTXFUGDVEO-UHFFFAOYSA-N |
Pubchem: | 216239 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | PRTN3 | CCLE | pan-cancer | AAC | 0.36 | 2e-15 |
mRNA | TYROBP | CCLE | pan-cancer | AAC | 0.37 | 9e-15 |
mRNA | TLR8 | CCLE | pan-cancer | AAC | 0.34 | 1e-14 |
mRNA | MS4A3 | CCLE | pan-cancer | AAC | 0.36 | 1e-14 |
mRNA | ADAMDEC1 | CCLE | pan-cancer | AAC | 0.35 | 1e-14 |
mRNA | PLPPR3 | CCLE | pan-cancer | AAC | 0.34 | 4e-14 |
mRNA | TPSAB1 | CCLE | pan-cancer | AAC | 0.34 | 5e-14 |
mRNA | SLC22A16 | CCLE | pan-cancer | AAC | 0.36 | 6e-14 |
mRNA | PRAM1 | CCLE | pan-cancer | AAC | 0.35 | 7e-14 |
mRNA | TGM5 | CCLE | pan-cancer | AAC | 0.33 | 2e-13 |